Adicet Bio Investor Relations Material
Latest events
Status Update
Adicet Bio
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from Adicet Bio Inc
Access all reports
Adicet Bio Inc. is a clinical-stage biotechnology company focused on the discovery and development of allogeneic gamma delta T cell therapies for cancer and other diseases. The company specializes in creating off-the-shelf genetically modified gamma delta T cells that selectively target tumors, leveraging the unique properties of these cells to offer a new generation of immune cell therapy. The company is headquartered in Redwood City, California, and its shares are listed on the Nasdaq.
Key slides for Adicet Bio Inc
9th Annual CAR-TCR U.S. Summit
Adicet Bio Inc
Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase 2024
Adicet Bio Inc
Latest articles
)
Lowe's Companies: Building a One-Stop Shop for Home Improvement
Lowe's Companies began as a single store in 1921 and has steadily expanded its footprint and offerings, now operating 1,750 stores across the U.S.
7 May 2025
)
Greg Abel: Succeeding Warren Buffett at Berkshire Hathaway
After decades working with Warren Buffett and Charlie Munger, Greg Abel was named Buffett’s successor as he steps down in late 2025.
5 May 2025
)
Intuitive Surgical: Enhancing Surgery with Robotic Precision
Intuitive Surgical has revolutionized surgery with robotics, building its dominant position through decades of innovation, validation, and expansion.
2 May 2025
Ticker symbol
ACET
Country
🇺🇸 United States